Roche Pharma India has announced the appointment of Rajwinder (Rajji) Mehdwan as country General Manager, effective 1 April 2025. She will also join the CEETRIS (Central Eastern Europe, Turkey, Russia & Indian Subcontinent) region leadership team, reporting to Francois du Toit, Area Head of CEETRIS, Roche Pharmaceuticals. Rajji joins at a time when Roche has been increasing its commitment to India by expanding into new therapy areas through innovative launches, strategic partnerships and investments.
Rajji brings over 20 years of experience in the healthcare industry, having held key leadership positions at Roche and prior to that at Johnson & Johnson. She joined Roche in 2010 as Associate Director, Virology and Specialty Care business for Genentech. Rajji has since contributed significantly to Roche’s success through her diverse leadership roles - as Portfolio Operations Leader for BioOncology, Portfolio Strategy Director for Denmark, and as the General Manager for Roche Pharma Norway.
Most recently, she led People & Culture for Roche’s Pharma International Business across 100+ markets and was part of the Roche Pharma International Leadership Team. During her stint in Norway, she was also the Chairwomen and Board Member, American Chamber of Commerce, Norway, and a Board Member of the Norway Pharmaceutical Industry Association.
Rajji holds a Bachelor’s degree from the Government College for Women, Ludhiana, Registered Nursing Degree from the Royal Free Hospital in London, and an MBA from the Wharton School, University of Pennsylvania.
Roche Pharma India also announces that V Simpson Emmanuel, who has served as General Manager since 2020 will step down due to personal reasons.
